Douglas C.A. Taylor

Statistics

Publications

Citations

642

H-Index

Active since

1981

Affiliations

Ironwood Pharmaceuticals (United States)(Current)

Optum (United States)

HealthInsight

Harvard University

Cabot (United States)

Douglas C.A. Taylor is an author at Ironwood Pharmaceuticals (United States) specializing in cost-effectiveness analysis, pharmacoeconomics, and pharmacy.

Publications per year

1981–2024

Publications

Cost Effectiveness of Denosumab versus Oral Bisphosphonates for Postmenopausal Osteoporosis in the US

Anju Parthan, Morgan Kruse, Nicole Yurgin et al. · Applied Health Economics and Health Policy · 2013 · 80 citations

Pharmacy, Pharmacoeconomics, Bone Metabolism +15

Comparative Cost-Effectiveness of Stereotactic Body Radiation Therapy Versus Intensity-Modulated and Proton Radiation Therapy for Localized Prostate Cancer

Anju Parthan, Narin Pruttivarasin, D.R.A. Davies et al. · Frontiers in Oncology · 2012 · 70 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Epidemiology, survival, and costs of localized gastrointestinal stromal tumors

Sanon, Sanon, Douglas C.A. Taylor et al. · International Journal of General Medicine · 2011 · 51 citations · Full text

Medicine, Oncology, Surgery +17

PRECURRENT SELF‐PROMPTING OPERANTS IN CHILDREN: “REMEMBERING”

Joseph A. Parsons, Douglas C.A. Taylor, Teresa Joyce · Journal of the Experimental Analysis of Behavior · 1981 · 41 citations · Full text

Social Sciences, Behavioral Sciences, Psychology +12

Methods of Model Calibration

Douglas C.A. Taylor, Vivek Pawar, Denise Kruzikas et al. · PharmacoEconomics · 2010 · 37 citations

Engineering, Systems Engineering, Method Validation +11

1–5 of 22